Effects of intravenous carrageenan on immune responses and on the reticulonendothelial system.
D000276:Adjuvants, Immunologic; D000818:Animals; D000917:Antibody Formation; D000941:Antigens; D002351:Carrageenan / Q000008:administration & dosage*; D004306:Dose-Response Relationship, Immunologic; D004912:Erythrocytes / Q000276:immunology; D006388:Hemagglutinins / Q000276:immunology; D006462:Hemolytic Plaque Technique; D007275:Injections, Intravenous; D008099:Liver / Q000276:immunology; D008168:Lung / Q000276:immunology; D008297:Male; D051379:Mice; D012157:Mononuclear Phagocyte System / Q000276:immunology*; D012756:Sheep; D013154:Spleen / Q000276:immunology; D013211:Staphylococcus aureus / Q000472:pathogenicity; D013997:Time Factors
D000276:Adjuvants, Immunologic; D000941:Antigens; D006388:Hemagglutinins; D002351:Carrageenan